Condition: Acute Necrotizing Pancreatitis · Pancreatic Exocrine Insufficiency · Sponsor: Asian Institute of Gastroenterology, India
In this multicenter, double blinded, placebo-controlled, 1:1 parallel group RCT, the investigators propose to evaluate the impact of pancreatic exocrine replacement therapy on patients with acute necrotizing pancreatitis (ANP). The investigators will include patients of 18-60yrs age and both genders with \>50% pancreatic parenchymal necrosis and at least 5% loss of body weight. The primary outcome measure is percent change in body weight at 3 months after enrolment. The intervention will include pancreatic enzyme consisting of 25000 IU of lipase and similar appearing placebo.
This description comes directly from the study's public registry record.
Abdul Rasheed, PharmD · +919652104726 · abdulrasheedmd1223@gmail.com
Always discuss trial participation with your own doctor first.
| Gauhati Medical College | Guwahati, Assam, India | Recruiting |
| Asian Institute of Gastroenterology Hospitals, Gachibowli | Hyderabad, Telangana, India | Recruiting |
| Asian Institute of Gastroenterology, Banjara Hills | Hyderabad, Telangana, India | Recruiting |
| ILS Hospital, Dum Dum | Kolkata, West Bengal, India | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07441824